News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genmab A/S (GEN.CO) Release: Daratumumab and Ofatumumab Data to Be Presented at American Society of Hematology


11/5/2012 9:12:42 AM

Copenhagen, Denmark; November 5, 2012 – Genmab A/S (OMX: GEN) announced today that six daratumumab and one ofatumumab abstract have been accepted for presentation at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition December 8-11 in Atlanta, Georgia. The abstracts are available on the ASH website at www.hematology.org.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES